Surgery Dealmaking Investigated in In-demand Study by CurrentPartnering Published at MarketPublishers.com01 Apr 2014 • by Natalie Aster
LONDON – Nowadays, most deals entered into by the global dominant healthcare companies are development or discovery stage thereby the licensee gets a right/option right to license the licensors’ surgery product or technology. Therefore, these surgery partnering deals tend to be multi-component, beginning with cooperative research and development, and also the outcomes of commercialisation efforts.
Knowing the flexibility of a would-be partner’s negotiated deals terms gives a profound insight into the negotiating procedure as to what results can be obtained following the negotiation of terms. While a great many small firms are expected to be looking for the details of various payment clauses, the primary challenge is in the detail regarding how the payments are triggered.
In-demand research study “Surgery Partnering 2009-2014” worked out by CurrentPartnering provides true insights into the surgery partnering deals and agreements entered into by the global top healthcare companies during 2009-2014.
The topical report presents a comprehensive analysis of surgery partnering deals; throws light on the trends prevailing in surgery partnering since 2009; contains an extensive summary of deals by stage of development, industry sector, technology type and deal type. The in-demand study is supplemented by a wealth of data illustrating financial side of deals, includes the surgery deals listing by headline value, signed by bigpharma, most active bigpharma. Each deal title is linked via Weblink to an on-line copy of the deal record, and where is available the contract document – thus granting easy access to every contract document requested. Besides, the report gives access to a whole set of important information a prospective dealmaker needs to know about the partnering activities in the commercialisation, research and development of surgery products and technologies.
Surgery Partnering 2009-2014
Published: March, 2014
Price: US$ 1,995.00
Other CurrentPartnering Reports on Healthcare Partnering Terms & Agreements:
- Seattle Genetics Partnering 2009-2014
- Diagnostics Deals and Alliances of 2013
- Anxiety Partnering 2009-2014
- Malaria Partnering 2009-2014
- Retinopathy Partnering 2009-2014
- Depression Partnering 2009-2014
- Cell Therapy Deals and Alliances of 2013
More in-demand research studies by the publisher can be found at CurrentPartnering page.